Inventor · disambiguated record
Arthur G. Taveras
Also filed as: TAVERAS ARTHUR · TAVERAS ARTHUR G · TAVERAS ARTHUR GEORGE
73 granted patents·28 pending applications·1,512 citations·filing 1995–2020
99Inventor score
Files withSCHERING CORP50BIOGEN MA INC14ALANTOS PHARM HOLDING9ALANTOS PHARMACEUTICALS INC3BIOGEN IDEC INC2
Top patents by PatentIndex Score
101 records- 0198US5874442ATricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseSCHERING CORP·Filed 1996·Granted Feb 23, 1999·129 cites·7 claims
- 0296US6387905B2Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2001·Granted May 14, 2002·59 cites·12 claims
- 0396US6372747B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Apr 16, 2002·93 cites·20 claims
- 0494US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0594US6432959B1Inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1999·Granted Aug 13, 2002·75 cites·6 claims
- 0694US6228856B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1999·Granted May 8, 2001·60 cites·24 claims
- 0792US10166250B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Jan 1, 2019·9 cites·11 claims
- 0892US9572824B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Feb 21, 2017·10 cites·14 claims
- 0992US8802659B2Bicyclic aryl sphingosine 1-phosphate analogsTHOMAS JERMAINE·Filed 2010·Granted Aug 12, 2014·20 cites·24 claims
- 1092US5719148ATricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 17, 1998·92 cites·47 claims
- 1191US9827258B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Nov 28, 2017·8 cites·10 claims
- 1291US9186367B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2014·Granted Nov 17, 2015·15 cites·14 claims
- 1391US6124295ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1999·Granted Sep 26, 2000·47 cites·18 claims
- 1491US6051582ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1998·Granted Apr 18, 2000·52 cites·19 claims
- 1590US6576639B1Compounds for the inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2000·Granted Jun 10, 2003·23 cites·19 claims
- 1690US5721236ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 24, 1998·72 cites·11 claims
- 1789US6040305ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1997·Granted Mar 21, 2000·60 cites·31 claims
- 1888US9771326B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Sep 26, 2017·6 cites·11 claims
- 1988US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 2088US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 2187US6362188B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Mar 26, 2002·85 cites·29 claims
- 2287US6075025ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1998·Granted Jun 13, 2000·34 cites·8 claims
- 2386US9550798B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 24, 2017·8 cites·25 claims
- 2486US6242458B1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Jun 5, 2001·25 cites·8 claims
- 2585US9555050B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 31, 2017·4 cites·24 claims
- 2685US7691851B2Metalloprotease inhibitors containing a heterocyclic moietyALANTOS PHARM HOLDING·Filed 2008·Granted Apr 6, 2010·10 cites·9 claims
- 2785US6903131B23,4-di-substituted maleimide compounds as CXC chemokine receptor antagonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Jun 7, 2005·28 cites·21 claims
- 2885US5696121ATricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Dec 9, 1997·50 cites·6 claims
- 2984US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 3084US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 3184US6878709B23,4-di-substituted pyridazinediones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·20 cites·4 claims
- 3284US5958940ATricyclic compounds useful as inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1997·Granted Sep 28, 1999·33 cites·17 claims
- 3383US7326729B2CXCR1 and CXCR2 chemokine antagonistsSCHERING CORP·Filed 2005·Granted Feb 5, 2008·6 cites·13 claims
- 3483US6365588B1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Apr 2, 2002·22 cites·11 claims
- 3582US9522889B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 20, 2016·5 cites·31 claims
- 3682US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 3779US7960433B2Treatment of chemokine mediated diseasesSCHERING CORP·Filed 2007·Granted Jun 14, 2011·4 cites·11 claims
- 3879US6492381B1Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 2000·Granted Dec 10, 2002·7 cites·9 claims
- 3979US6071907ATricyclic compounds useful as FPT inhibitorsSCHERING CORP·Filed 1997·Granted Jun 6, 2000·21 cites·12 claims
- 4079US5728703ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Mar 17, 1998·34 cites·16 claims
- 4178US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 4278US7553861B2Dipeptidyl peptidase-IV inhibitorsALANTOS PHARM HOLDING·Filed 2006·Granted Jun 30, 2009·3 cites·6 claims
- 4378US5807853ATricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Sep 15, 1998·18 cites·22 claims
- 4477US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 4577US5861395ACompounds useful for inhibition of farnesyl proteins transferaseSCHERING CORP·Filed 1997·Granted Jan 19, 1999·22 cites·32 claims
- 4676US8207221B2Crystalline polymorphs of a CXC-chemokine receptor ligandHU MENGWEI·Filed 2008·Granted Jun 26, 2012·2 cites·5 claims
- 4776US8076330B2Dipeptidyl peptidase-IV inhibitorsKROTH HEIKO·Filed 2011·Granted Dec 13, 2011·4 cites·24 claims
- 4874US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 4973US5877177ACarboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1997·Granted Mar 2, 1999·31 cites·17 claims
- 5072US8835441B2Heterobicyclic metalloprotease inhibitorsSTEENECK CHRISTOPH·Filed 2011·Granted Sep 16, 2014·3 cites·10 claims
Showing the top 50 of 101 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Arthur G. Taveras files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →